ATE494370T1 - Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren - Google Patents

Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren

Info

Publication number
ATE494370T1
ATE494370T1 AT03748973T AT03748973T ATE494370T1 AT E494370 T1 ATE494370 T1 AT E494370T1 AT 03748973 T AT03748973 T AT 03748973T AT 03748973 T AT03748973 T AT 03748973T AT E494370 T1 ATE494370 T1 AT E494370T1
Authority
AT
Austria
Prior art keywords
nucleic acids
transposon
integration
based vectors
compositions
Prior art date
Application number
AT03748973T
Other languages
English (en)
Inventor
Joseph Kaminski
Original Assignee
Manoa Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manoa Biosciences Inc filed Critical Manoa Biosciences Inc
Application granted granted Critical
Publication of ATE494370T1 publication Critical patent/ATE494370T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03748973T 2002-07-24 2003-07-24 Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren ATE494370T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39862802P 2002-07-24 2002-07-24
PCT/US2003/023090 WO2004009792A2 (en) 2002-07-24 2003-07-24 Transposon-based vectors and methods of nucleic acid integration

Publications (1)

Publication Number Publication Date
ATE494370T1 true ATE494370T1 (de) 2011-01-15

Family

ID=30771227

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03748973T ATE494370T1 (de) 2002-07-24 2003-07-24 Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren

Country Status (9)

Country Link
US (1) US20060210977A1 (de)
EP (1) EP1546322B1 (de)
AT (1) ATE494370T1 (de)
AU (1) AU2003268022B2 (de)
CA (1) CA2533708C (de)
DE (1) DE60335637D1 (de)
ES (1) ES2358994T3 (de)
SI (1) SI1546322T1 (de)
WO (1) WO2004009792A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527966B2 (en) * 2002-06-26 2009-05-05 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
US20040172667A1 (en) 2002-06-26 2004-09-02 Cooper Richard K. Administration of transposon-based vectors to reproductive organs
US20080008687A1 (en) * 2003-02-10 2008-01-10 Max-Delbruck-Centrum Fur Molekulare Medizin (Mdc) Transposon-Based Targeting System
ATE536419T1 (de) * 2003-02-10 2011-12-15 Max Delbrueck Centrum Transposon basiertes targeting- system
DE602004031284D1 (de) * 2003-02-10 2011-03-17 Max Delbrueck Centrum Transposon-system zur gezielten integration
US8071364B2 (en) 2003-12-24 2011-12-06 Transgenrx, Inc. Gene therapy using transposon-based vectors
US20050215507A1 (en) * 2004-03-04 2005-09-29 Massachusetts Institute Of Technology Therapeutic anti-cancer DNA
US7842503B2 (en) 2004-04-30 2010-11-30 Poetic Genetics, Llc Hybrid recombinases for genome manipulation
WO2006078431A2 (en) 2004-12-22 2006-07-27 The University Of Iowa Research Foundation Compositions and methods related to modified retroviral vectors for restricted, site specific integration
US7919583B2 (en) 2005-08-08 2011-04-05 Discovery Genomics, Inc. Integration-site directed vector systems
WO2008100424A2 (en) * 2007-02-09 2008-08-21 University Of Hawaii Animals and cells with genomic target sites for transposase-mediated transgenesis
WO2008137114A1 (en) * 2007-05-04 2008-11-13 University Of Hawai'i Methods and compositions for targeted delivery of gene therapeutic vectors
US20090042297A1 (en) * 2007-06-01 2009-02-12 George Jr Alfred L Piggybac transposon-based vectors and methods of nucleic acid integration
JP2010529862A (ja) * 2007-06-16 2010-09-02 スカラブ ゲノミクス， エルエルシー 核酸パッケージングシステム
CN101503670B (zh) * 2008-02-04 2011-12-14 复旦大学附属华山医院 一种含有整合子的工程菌株
US8309791B2 (en) * 2008-07-16 2012-11-13 Recombinectics, Inc. Method for producing a transgenic pig using a hyper-methylated transposon
WO2010036978A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of growth hormone
US9150880B2 (en) 2008-09-25 2015-10-06 Proteovec Holding, L.L.C. Vectors for production of antibodies
WO2010085699A2 (en) * 2009-01-23 2010-07-29 The Johns Hopkins University Mammalian piggybac transposon and methods of use
GB2467167B (en) 2009-01-26 2013-09-11 Algentech Sas Gene targeting in plants
WO2010118360A1 (en) 2009-04-09 2010-10-14 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Production of proteins using transposon-based vectors
CN107312796A (zh) 2010-12-15 2017-11-03 大学共同利用机关法人情报·系统研究机构 蛋白质的生产方法
EP3019618B1 (de) * 2013-07-12 2018-10-31 University of South Alabama Minimale piggybac-vektoren für genomische integration
BR112018005620A2 (pt) * 2015-09-22 2018-10-09 Univ Wuerzburg J Maximilians método para transferência de gene estável e de nível elevado em linfócitos
CN105154473B (zh) * 2015-09-30 2019-03-01 上海细胞治疗研究院 一种高效安全的转座子整合系统及其用途
CN105481984B (zh) * 2015-12-03 2020-09-22 上海细胞治疗研究院 一种高效介导外源基因整合的转座酶及其用途
JP2021519073A (ja) 2018-03-29 2021-08-10 ジェネンテック， インコーポレイテッド 哺乳動物細胞におけるラクトジェニック活性の制御
KR20210126564A (ko) * 2019-02-13 2021-10-20 프로바이오겐 아게 향상된 삽입 부위 선택 특성을 지닌 트랜스포사제(transposase)
BR112021024828A2 (pt) * 2019-06-11 2022-01-25 Univ Pompeu Fabra Construtos de edição de gene alvejado e métodos de uso dos mesmos
EP3835421A1 (de) * 2019-12-11 2021-06-16 Consejo Superior de Investigaciones Científicas (CSIC) Vektoren für gewebespezifische transkriptomik
TW202202620A (zh) 2020-03-26 2022-01-16 美商建南德克公司 經修飾之哺乳動物細胞
CA3173889A1 (en) 2020-05-04 2021-11-11 Saliogen Therapeutics, Inc. Transposition-based therapies
MX2022016453A (es) 2020-06-24 2023-02-01 Genentech Inc Lineas celulares resistentes a la apoptosis.
WO2022012758A1 (en) 2020-07-17 2022-01-20 Probiogen Ag Hyperactive transposons and transposases
CA3215965A1 (en) 2021-04-19 2022-10-27 Amy Shen Modified mammalian cells
JP2024521107A (ja) 2021-05-21 2024-05-28 ジェネンテック， インコーポレイテッド 目的の組換え産物を産生するための修飾細胞
WO2023039434A1 (en) * 2021-09-08 2023-03-16 Metagenomi, Inc. Systems and methods for transposing cargo nucleotide sequences
KR20240117146A (ko) 2021-12-22 2024-07-31 제넨테크, 인크. 다중 벡터 재조합효소 매개 카세트 교환
WO2024068845A1 (en) * 2022-09-29 2024-04-04 Vib Vzw New loxpsym sites for large-scale orthogonal cre-mediated recombination

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225121B1 (en) * 1992-09-14 2001-05-01 Institute Of Molecular Biology And Biotechnology/Forth Eukaryotic transposable element
US6150511A (en) * 1995-05-09 2000-11-21 Fox Chase Cancer Center Chimeric enzyme for promoting targeted integration of foreign DNA into a host genome
AU5741996A (en) * 1995-05-22 1996-12-11 Chiron Corporation Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
WO1997020038A1 (en) * 1995-12-01 1997-06-05 The Regents Of The University Of California Compositions and methods for site-directed integration into dna
WO1999053017A2 (en) * 1998-04-15 1999-10-21 Fred Hutchinson Cancer Research Center Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene
WO2001030965A2 (en) * 1999-10-28 2001-05-03 The Board Of Trustees Of The Leland Stanford Junior University Methods of in vivo gene transfer using a sleeping beauty transposon system
IL154059A0 (en) * 2000-07-21 2003-07-31 Syngenta Participations Ag Zinc finger domain recognition code and uses thereof
US20020132350A1 (en) * 2000-09-14 2002-09-19 Pioneer Hi-Bred International, Inc. Targeted genetic manipulation using Mu bacteriophage cleaved donor complex
EP1308516A1 (de) * 2001-10-24 2003-05-07 ADEREGEM (Association pour le Développement de la Recherche en Génétique Moléculaire Zielgerichtete Rekombinase-Fusionsproteine und entsprechende Polynukleotide, Vektoren und Kits, und deren Verwendungen zur zielgerichteten DNS-Rekombination

Also Published As

Publication number Publication date
US20060210977A1 (en) 2006-09-21
EP1546322A2 (de) 2005-06-29
AU2003268022A1 (en) 2004-02-09
AU2003268022B2 (en) 2009-02-05
SI1546322T1 (sl) 2011-05-31
WO2004009792A3 (en) 2004-05-13
DE60335637D1 (de) 2011-02-17
EP1546322B1 (de) 2011-01-05
WO2004009792A2 (en) 2004-01-29
CA2533708C (en) 2013-05-14
ES2358994T3 (es) 2011-05-17
EP1546322A4 (de) 2006-07-19
CA2533708A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
ATE494370T1 (de) Vektoren auf transposonbasis und verfahren zur integration von nukleinsäuren
EP4253551A3 (de) Neuartige, auf dna und rna gerichtete crispr enzyme und systeme
EP4257696A3 (de) Neuartige, auf dna gerichtete crispr enzyme und systeme
PH12021550904A1 (en) Novel crispr/cas12f enzyme and system
WO2007014275A3 (en) Targeted integration and expression of exogenous nucleic acid sequences
WO2005047511A3 (en) Bacterial expression of protease inhibitors and variants thereof
DK1513952T3 (da) Sammensætninger og fremgangsmåder til frembringelse af nukleinsyre af sputum
WO2003080807A3 (en) Compositions and methods for suppressing eukaryotic gene expression
DE602007012858D1 (de) Verfahren zur durchführung homologer rekombinationen in pflanzen
WO2004044181A3 (en) Antisense modulation of apolipoprotein b expression
WO2004002417A3 (en) Mammalian ch1 deleted mimetibodies, compositions, methods and uses
ZA202202628B (en) Novel crispr dna targeting enzymes and systems
DE50311850D1 (de) Konstrukte und verfahren zur regulation der genexpression
MX2007008065A (es) Composiciones y metodos para modular la expresion genica usando oligonucleotidos autoprotegidos.
ATE536415T1 (de) Klonierung des cytochrome p450 gens von nicotiana
WO2003097662A8 (en) Antisense modulation of apolipoprotein b expression
DK1053313T3 (da) Optimerede antisense oligonucleotider komplementære til DNA methyltransferase-sekvenser
WO2001070777A3 (en) Leafy cotyledon2 genes and their uses
EA201070229A1 (ru) Нуклеотидные последовательности msca1, влияющие на мужскую фертильность растений, и способ их применения
WO2003097810A3 (en) Nitrilases, nucleic acids encoding them and methods for making and using them
WO2004010925A3 (en) Mammalian genes involved in viral infection and tumor suppression
WO2008133749A3 (en) Antimicrobial agents from microbial genomes
ATE420975T1 (de) Methode zur linearen nicht-selektiven amplifikation von nukleinsäuren
DK1766036T3 (da) Fremgangsmåde til fjernelse af selekterbare markørgensekvenser
MXPA02012557A (es) Composiciones y metodos para la modificacion de la expresion del gen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties